Jonathan Yong
Stock Analyst at UBS
(2.60)
# 2,259
Out of 5,030 analysts
97
Total ratings
60.38%
Success rate
11.08%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHTH eHealth | Maintains: Neutral | $7 → $5 | $4.77 | +4.82% | 6 | Aug 7, 2025 | |
| CLOV Clover Health Investments | Maintains: Neutral | $4.5 → $3 | $2.71 | +10.70% | 4 | Aug 6, 2025 | |
| OSCR Oscar Health | Downgrades: Sell | $15 → $11 | $19.39 | -43.27% | 8 | Jul 15, 2025 | |
| PINC Premier | Maintains: Neutral | $33 → $25 | $28.00 | -10.71% | 2 | Aug 24, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $8.06 | +48.88% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $3.83 | +108.88% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $12.63 | +105.86% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $49.78 | -71.88% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $62.98 | +52.43% | 3 | Aug 8, 2023 | |
| SEM Select Medical Holdings | Maintains: Neutral | $29 → $32 | $13.39 | +138.98% | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $105 | $19.67 | +433.81% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $124.55 | -35.77% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $285.94 | -19.21% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $8.53 | +216.53% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $156.41 | -36.07% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $786.00 | -42.75% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $2.87 | +318.12% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $5.45 | +1,184.40% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $16.35 | +3.98% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $192.68 | +81.65% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $24.17 | +293.13% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $4.40 | +93.18% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $25.53 | +60.60% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $4.80 | +254.17% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $3.08 | +175.97% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $82.29 | +3.29% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $189.51 | -22.96% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $35.27 | +200.54% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $204.56 | -23.25% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $299.27 | +22.97% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $275.01 | +130.90% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $82.52 | +41.78% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $16.45 | +82.37% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $426.16 | -30.07% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $200.00 | -52.50% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $356.60 | +38.81% | 1 | Oct 15, 2021 |
eHealth
Aug 7, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $4.77
Upside: +4.82%
Clover Health Investments
Aug 6, 2025
Maintains: Neutral
Price Target: $4.5 → $3
Current: $2.71
Upside: +10.70%
Oscar Health
Jul 15, 2025
Downgrades: Sell
Price Target: $15 → $11
Current: $19.39
Upside: -43.27%
Premier
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $25
Current: $28.00
Upside: -10.71%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $8.06
Upside: +48.88%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $3.83
Upside: +108.88%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $12.63
Upside: +105.86%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $49.78
Upside: -71.88%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $62.98
Upside: +52.43%
Select Medical Holdings
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $13.39
Upside: +138.98%
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $19.67
Upside: +433.81%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $124.55
Upside: -35.77%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $285.94
Upside: -19.21%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $8.53
Upside: +216.53%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $156.41
Upside: -36.07%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $786.00
Upside: -42.75%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $2.87
Upside: +318.12%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $5.45
Upside: +1,184.40%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $16.35
Upside: +3.98%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $192.68
Upside: +81.65%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $24.17
Upside: +293.13%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $4.40
Upside: +93.18%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $25.53
Upside: +60.60%
Mar 7, 2023
Maintains: Neutral
Price Target: $20 → $17
Current: $4.80
Upside: +254.17%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $3.08
Upside: +175.97%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $82.29
Upside: +3.29%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $189.51
Upside: -22.96%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $35.27
Upside: +200.54%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $204.56
Upside: -23.25%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $299.27
Upside: +22.97%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $275.01
Upside: +130.90%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $82.52
Upside: +41.78%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $16.45
Upside: +82.37%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $426.16
Upside: -30.07%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $200.00
Upside: -52.50%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $356.60
Upside: +38.81%